{
  "id": 26074,
  "title": "Regeneron, Sanofi tease potential expanded collaboration for Dupixent follow-ons",
  "url": "https://urgent.news/2026/07/30/regeneron-sanofi-tease-potential-expanded-collaboration-for-dupixent",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-30T19:22:42.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/regeneron-sanofi-tease-potential-expanded-collaboration-for-dupixent-follow-ons/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Regeneron and Sanofi said they are in the early stages of discussing areas for further collaboration, building on one of the most fruitful pharmaceutical company partnerships in recent history. An expanded deal could include follow-on ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Takeda, Regeneron, Sanofi and Bristol Myers trim pipelines",
        "url": "https://urgent.news/2026/07/30/takeda-regeneron-sanofi-and-bristol-myers-trim-pipelines",
        "published": "2026-07-30T15:02:43.000Z"
      },
      {
        "outlet": "BioPharma Dive",
        "title": "Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs",
        "url": "https://urgent.news/2026/07/31/sanofi-to-rebuild-trust-with-regeneron-apnimed-adds-to-string-of",
        "published": "2026-07-31T15:06:47.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}